Question 30 | |
Question 7 | Immune suppression: timing of infection following transplant |
Question 27 | |
Question 21 | Invasive fungal infection, aspergillosis and antifungal choices |
Question 4 | Empyema; also vancomycin vs. linezolid |
Question 28.3 | Cytomegalovirus: specifically, colitis |
Question 28.2 | |
Question 28.1 | "Name That Microbe": Gram-positive cocci in the CSF |
Question 26 | |
Question 21.3 | Malaria: diagnosis, severity features, management |
Question 2 |
Question 22 | |
Question 19 | Clostridium difficile: investigations, clinical features, management |
Question 1 | Staphylococcal bacteraemia: assessment and management |
Question 28 | |
Question 27 | Necrotising fasciitis - specifically, associated with Group A Streptococci |
Question 5 |
Question 23 | |
Question 12 | Tuberculosis: investigations and infection control precautions |
Question 21.3 | Cryptococcus meningitis in a patient with AIDS |
Question 21.2 | Listeria monocytogenes meningitis |
Question 21.1 | CSF analysis in meningitis |
Question 28 | Infection control measures for different organisms |
Question 26 | Meningitis - in a neonate, but without a paediatric flavour |
Question 25 | |
Question 1 |
Question 15.1 | Approach to the hideous whole-body rash - purpura fulminans again |
Question 13 | Ventilator-associated pneumonia: nebulised antibiotics |
Question 6.3 | Meningitis - when not to LP |
Question 6.2 | Meningitis - ventriculitis |
Question 6.1 | Meningitis - microbiology and investigations |
Question 4 |
Question 30.1 | Clinical diagnosis of infective endocarditis |
Question 21 | |
Question 20 | |
Question 4 | |
Question 1 | C.difficile colitis: risk factors, transmission prevention, diagnosis, management |
Question 20 | How to manage multidrug-resistant Gram-negatives |
Question 4 | Spontaneous bacterial peritonitis and causes of decompensation in liver disease |
Question 2 | Community-acquired pneumonia: risk stratification |
Question 26 | |
Question 22 | |
Question 21 | |
Question 18 | |
Question 14 | Coagulase-negative staphylococci and the meaning of positive blood cultures |
Question 6 | Tetanus, again! |
Question 15.2 | Management of meningitis post trans-sphenoidal surgery |
Question 14 | Name that organism: cultures from a festering pancreatitis patient |
Question 28 | Sepsis in the heart and lung transplant recipient - a pneumonia, of course |
Question 9 | |
Question 6 | Biomarkers of sepsis: procalcitonin in some detail |
Question 2 | Necrotising fasciitis - specifically, associated with Group A Streptococci |
Question 30.2 | Listeria: a game of "Name That Microbe". Also, risk factors and treatment options. |
Question 30.1 | Mucor: a game of "Name That Microbe". Also, risk factors and treatment options. |
Question 25 | Necrotising fasciitis: management priorities within the first 24 hours |
Question 12 | Clostridium difficile: also, strategies to prevent the transmission of multi-resistant organisms |
Question 5 | Community-acquired pneumonia: critically evaluate the role of steroids |
Question 1 | Severe acute pancreatitis: role of antibiotics |
Question 22 | Viral haemorrhagic fever (Ebola) |
Question 19 | Antibiotic dose adjustment: a variation of kill characteristics of antibiotic agents |
Question 12 | |
Question 10 | Pharmacokinetics of antibiotics in critical illness: specifically, in septic shock |
Question 28 | |
Question 27 | General principles of antibiotic use: factors which influence the choice of agent |
Question 25 | Ventilator-associated pneumonia (VAP): organisation-level strategies for prevention |
Question 21.2 | Antibiotic choices for selected pathogens: specific context of meningitis |
Question 19 | HIV and AIDS: relevant investigations and antiretroviral pharmacology |
Question 11 | Meningitis: specifically, common pathogens and role of steroids |
Question 5 | Management of the staff member with a needle stick injury. |
Question 29.1 | Clinical features of infective endocarditis other than fever and murmur. |
Question 18 | All about the significance of the endothelial glycocalyx in sepsis. |
Question 9 | Aspergillosis: specifically, issues related to its diagnosis |
Question 7 | Leptospirosis, in frightening detail |
Question 3.3 | |
Question 3.2 | |
Question 3.1 | |
Question 1 |
Question 14 | Clostridium difficile again: risk factors, diagnosis, complications, prevention, treatment. |
Question 11 | Sepsis in the bone marrow transplant recipient (also, causes of diarrhoea) |
Question 3.3 | Acronymous organisms: ESCAPPM and HACEK organisms again. |
Question 3.2 | Necrotising fasciitis of the abdominal wall. Also a game of "Name That Microbe." |
Question 1 |
Question 22 | Critically evaluate the role of vasopressin in resuscitation of septic shock. |
Question 16 | |
Question 15.2 | Antibiotic dosing in renal failure (for patients who are not on dialysis) |
Question 15.1 | |
Question 14 | A critique of selective digestive tract decontamination (SDD) |
Question 12 | Tetanus! Specific management of tetanus. |
Question 23.3 | "Name That Microbe" - specifically, which Gram-negatives have innate imipenem resistance |
Question 23.2 | Vibrio vulnificus: a game of "Name That Microbe" |
Question 23.1 | The meaning of positive blood cultures taken from a CVC (S.epidermidis) |
Question 19 | H1N1 "Swine Flu" influenza - diagnosis and management. |
Question 16 | Corticosteroids in septic shock, again. |
Question 9 |
Question 7 | Community-acquired pneumonia: evaluation of the non-resolving pneumonia. |
Question 3.3 | Meningitis in general; specifically, aseptic meningitis. |
Question 2 |
Question 30 | |
Question 18 | Community-acquired pneumonia: prognosis, organisms, empiric treatment. |
Question 6 | Haemoptysis in an abattoir worker; another game of "Name That Microbe". |
Question 3 | Clostridium difficile; what causes "infective diarrhoea" in the critically ill? |
Question 25 | Malaria: diagnosis, management and complications |
Question 19 | |
Question 18 | Which antibiotic choice would be appropriate (abdominal catastrophe) |
Question 24 | Necrotising fasciitis: "management priorities" |
Question 11 | Which antibiotic choice would be appropriate for these MROs. |
Question 7 | Your ICU is a filthy zoo. Discuss strategies to prevent the transmission of MROs. |
Question 21 | Cytomegalovirus infection in the immunocompetent patient. |
Question 17.3 | |
Question 17.2 | "Name That Microbe": Historical features associated with specific pathogens |
Question 17.1 | Choice of appropriate antibiotics for this list of organisms. |
Question 14.2 | Differential diagnosis of purpura fulminans; possibly meningococcal sepsis. |
Question 14.1 | Necrotising fasciitis: Fournier's gangrene. 2 important management steps. |
Question 23 | Critical evaluation of procalcitonin; a variant of the biomarkers of sepsis |
Question 13 | Antibiotics for MRSA, antifungals, and antibiotic dosing in renal failure. |
Question 25.4 | "Name That Microbe": pneumonia, arthralgia and a new murmur in a cattle farmer |
Question 25.3 | "Name That Microbe": which Gram-negatives have innate imipenem resistance? |
Question 25.2 | "Name That Microbe": which Gram-positive bacillus is causing this meningitis ? |
Question 20 | Clinical features and management of malaria. |
Question 9 | Infectious and non-infectious causes of fever. Also, biomarkers of sepsis |
Question 29.1 | "Name That Rash" - Varicella zoster virus and VZV pneumonia. |
Question 25.3 | |
Question 25.2 | |
Question 25.1 | Necrotising fasciitis of the abdominal wall. |
Question 22 | Sepsis in the heart-lung transplant recipient; also, complications of this transplant. |
Question 21 | Noradrenaline in resuscitation of septic shock; also calculation of the SVR. |
Question 25.3 | "Name That Microbe": Pneumonia arthralgia and a new murmur in a cattle farmer |
Question 25.2 | Acronymous organisms: ESCAPPM and HACEK organisms again. |
Question 25.1 | "Name That Microbe": Gram-positive bacillus in the CSF |
Question 17 | Acalculous cholecystitis: clinical features, investigations and management |
Question 12 | |
Question 11.2 | "Does this CSF look infected to you?" ... a case of meningitis |
Question 24.3 | Acronymous organisms: ESCAPPM and HACEK organisms again. |
Question 24.2 | Which antibiotic choice would be appropriate to treat this Proteus infection? |
Question 24.1 | |
Question 22 | |
Question 21 | Infective endocarditis. Particularly, what are the indications for emergency valve replacement? |
Question 13 | Which antibiotic choice would be appropriate (abdominal catastrophe). |
Question 1 |
Question 27 | The difficulty in making a diagnosis of sepsis; also, lets talk about biomarkers of sepsis |
Question 26 | |
Question 25 | Management of the staff member with a needle stick injury. |
Question 19 |
Question 26 | Community acquired pneumonia: specifically, historical features of special relevance. |
Question 8 | Central line-associated bacteraemia - specifically, preventative steps. |
Question 27 | Pseudomembranous colitis: "likely causes" (its not always Clostridium difficile) |
Question 7 | Inotropes in resuscitation of septic shock: comparison of adrenaline, dopamine and dobutamine. |
Question 13 | SARS pneumonia: risk factors and management strategies. |
Question 9 | |
Question 2b | Infectious and non-infectious causes of fever: a post-operative scenario |
Question 3 | Pharmacology of antifungal agents: Fluconazole; "critically evaluate" fluconazole. |
Question 1b | Enterococcus faecalis and faecium: significance of a bacteraemia |
Question 2d | Community acquired pneumonia: when to escalate or de-escalate antibiotics. |
Question 2c | Community acquired pneumonia: empiric antibiotic therapy. |
Question 2b | Community-acquired pneumonia: investigations. |
Question 2a | Community-acquired pneumonia: historical features |
Question 9 | Pneumonia in the immunocompromised host: specifically, in AIDS. |
Question 1c |
Question 10 | |
Question 8 | Acalculous cholecystitis: clinical features, investigations and management |
Question 1 | Infectious and non-infectious causes of fever and the management of fever. |
Question 10 | Prevention of nosocomial infections in the ICU |
Question 1 | Necrotising fasciitis: diagnostic features and priorities of management. |
Question 14 | Implications of increasing antibiotic resistance on ICU practice |
Question 10 | Corticosteroids in septic shock (or...refractory shock in general?) |
Question 5 | Antibiotic pharmacology - compare benzylpenicillin, ciprofloxacin and cotrimoxazole |
Question 2 | Central line-associated bacteraemia and preventative measures. |
Question 13 | Malaria. Discuss management. |
Question 1 | Pharmacokinetics and pharmacodynamics of antibiotics in critical illness. |
Question 1c |